• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从咔啉和喹啉数据库中发现严重急性呼吸综合征冠状病毒2主要蛋白酶抑制剂

discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database.

作者信息

Muhtar Eldar, Wang Mengyang, Zhu Haimei

机构信息

Beijing Area Major Laboratory of Peptide & Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory of Biomedical Materials, College of Pharmaceutical Sciences of Capital Medical University, Beijing, 100069, China.

出版信息

Future Virol. 2021 Jul. doi: 10.2217/fvl-2021-0099. Epub 2021 Jul 20.

DOI:10.2217/fvl-2021-0099
PMID:34306166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8293686/
Abstract

SARS-CoV-2 caused more than 3.8 million deaths according to the WHO. In this urgent circumstance, we aimed at screening out potential inhibitors targeting the main protease of SARS-CoV-2. An in-house carboline and quinoline database including carboline, quinoline and their derivatives was established. A virtual screening in carboline and quinoline database, 50 ns molecular dynamics simulations and molecular mechanics Poisson-Boltzmann surface area calculations were carried out. The top 12 molecules were screened out preliminarily. The molecular mechanics Poisson-Boltzmann surface area ranking showed that p59_7m, p12_7e, p59_7k stood out with the lowest binding energies of -24.20, -17.98, -17.67 kcal/mol, respectively. The study provides powerful results that indicate the selected molecules are valuable for further evaluation as SARS-CoV-2 main protease inhibitors.

摘要

据世界卫生组织统计,新型冠状病毒肺炎已导致超过380万人死亡。在此紧急情况下,我们旨在筛选出针对新型冠状病毒主要蛋白酶的潜在抑制剂。建立了一个内部咔啉和喹啉数据库,其中包括咔啉、喹啉及其衍生物。在咔啉和喹啉数据库中进行了虚拟筛选、50纳秒分子动力学模拟以及分子力学泊松-玻尔兹曼表面积计算。初步筛选出了排名前12的分子。分子力学泊松-玻尔兹曼表面积排名显示,p59_7m、p12_7e、p59_7k表现突出,其结合能分别为-24.20、-17.98、-17.67千卡/摩尔,为最低。该研究提供了有力结果,表明所筛选出的分子作为新型冠状病毒主要蛋白酶抑制剂具有进一步评估的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/528d92836bef/figure6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/c1f4280a6189/figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/11d342739beb/figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/1566a9c225fe/figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/ffb0d46b0729/figure4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/8455d94ea446/figure5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/528d92836bef/figure6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/c1f4280a6189/figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/11d342739beb/figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/1566a9c225fe/figure3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/ffb0d46b0729/figure4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/8455d94ea446/figure5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9966/8293686/528d92836bef/figure6.jpg

相似文献

1
discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database.从咔啉和喹啉数据库中发现严重急性呼吸综合征冠状病毒2主要蛋白酶抑制剂
Future Virol. 2021 Jul. doi: 10.2217/fvl-2021-0099. Epub 2021 Jul 20.
2
In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.基于计算机的药物发现:香料中的主要代谢物可作为 SARS-CoV-2 主蛋白酶抑制剂。
Comput Biol Med. 2020 Nov;126:104046. doi: 10.1016/j.compbiomed.2020.104046. Epub 2020 Oct 8.
3
In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.通过分子对接、MMGBSA 预测结合能计算和分子动力学模拟,从计算机上鉴定潜在的关键 SARS-CoV-2 3CL 水解酶(Mpro)抑制剂。
PLoS One. 2020 Jul 24;15(7):e0235030. doi: 10.1371/journal.pone.0235030. eCollection 2020.
4
analyses of major active constituents of fingerroot () unveils inhibitory activities against SARS-CoV-2 main protease enzyme.对莪术()主要活性成分的分析揭示了其对新型冠状病毒主要蛋白酶的抑制活性。
Saudi J Biol Sci. 2022 Jan;29(1):65-74. doi: 10.1016/j.sjbs.2021.11.053. Epub 2021 Nov 26.
5
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.基于药物再利用的分子对接和动力学模拟预测 SARS-CoV-2 主要蛋白酶的潜在抑制剂的计算机预测。
J Infect Public Health. 2020 Sep;13(9):1210-1223. doi: 10.1016/j.jiph.2020.06.016. Epub 2020 Jun 16.
6
Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.揭示瑞德西韦和核苷酸类似物对 SARS-CoV-2 的 RNA 依赖性 RNA 聚合酶(RdRp)的抑制机制:分子动力学模拟研究。
J Phys Chem B. 2020 Nov 25;124(47):10641-10652. doi: 10.1021/acs.jpcb.0c06747. Epub 2020 Nov 15.
7
Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study.探索用于寻找新型冠状病毒主要蛋白酶抑制剂的毒素:分子对接、分子动力学、药代动力学性质及反应组学研究
Pharmaceuticals (Basel). 2022 Jan 27;15(2):153. doi: 10.3390/ph15020153.
8
Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2.利用综合计算方法来确定 SARS-CoV-2 的安全和快速治疗方法。
J Biomol Struct Dyn. 2021 Jun;39(9):3387-3395. doi: 10.1080/07391102.2020.1764392. Epub 2020 May 15.
9
Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations.基于配体/基于结构的虚拟筛选、分子动力学模拟和结合能计算发现 SARS-CoV-2 主要蛋白酶的有效抑制剂。
Phys Chem Chem Phys. 2020 Oct 21;22(40):23099-23106. doi: 10.1039/d0cp04326e.
10
Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.利用分子对接方法从美国食品药品监督管理局(FDA)批准的抗病毒药物中进行双重抑制剂对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白和主要蛋白酶的计算筛选。
Acta Virol. 2021;65(2):160-172. doi: 10.4149/av_2021_208.

引用本文的文献

1
Evaluation of SARS-CoV-2 main protease and inhibitor interactions using dihedral angle distributions and radial distribution function.利用二面角分布和径向分布函数评估严重急性呼吸综合征冠状病毒2主要蛋白酶与抑制剂的相互作用。
Heliyon. 2021 Oct;7(10):e08220. doi: 10.1016/j.heliyon.2021.e08220. Epub 2021 Oct 19.

本文引用的文献

1
COVID-19 vaccination and dialysis patients: why the variable response.COVID-19 疫苗接种和透析患者:为何反应不一。
QJM. 2021 Nov 5;114(7):440-444. doi: 10.1093/qjmed/hcab171.
2
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection.考虑用于发现和开发针对 SARS-CoV-2 感染的 3-糜蛋白酶样半胱氨酸蛋白酶抑制剂。
Curr Opin Virol. 2021 Aug;49:36-40. doi: 10.1016/j.coviro.2021.04.006. Epub 2021 Apr 27.
3
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M) Inhibitors.
基于红海中无脊椎动物的萜类化合物的计算机挖掘,寻找 SARS-CoV-2 主蛋白酶(M)抑制剂。
Molecules. 2021 Apr 5;26(7):2082. doi: 10.3390/molecules26072082.
4
Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study.芦丁及黄酮类似物作为潜在的新型冠状病毒主要蛋白酶抑制剂:计算机辅助药物发现研究
J Mol Graph Model. 2021 Jun;105:107904. doi: 10.1016/j.jmgm.2021.107904. Epub 2021 Mar 20.
5
In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.计算机模拟评估有潜力的抗 COVID-19 药物候选物作为潜在的 SARS-CoV-2 主要蛋白酶抑制剂。
Protein J. 2021 Jun;40(3):296-309. doi: 10.1007/s10930-020-09945-6. Epub 2021 Jan 2.
6
Remdesivir Approved to Treat COVID-19 Amid Controversy.瑞德西韦在争议声中获批用于治疗新冠肺炎。
Am J Nurs. 2021 Jan 1;121(1):22-24. doi: 10.1097/01.NAJ.0000731640.35662.2c.
7
Targeting Proteases for Treating COVID-19.靶向蛋白酶治疗 COVID-19。
J Proteome Res. 2020 Nov 6;19(11):4316-4326. doi: 10.1021/acs.jproteome.0c00430. Epub 2020 Oct 22.
8
In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.基于计算机的药物发现:香料中的主要代谢物可作为 SARS-CoV-2 主蛋白酶抑制剂。
Comput Biol Med. 2020 Nov;126:104046. doi: 10.1016/j.compbiomed.2020.104046. Epub 2020 Oct 8.
9
drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors.药物重定位和分子动力学解析出潜在的 SARS-CoV-2 主要蛋白酶抑制剂。
J Biomol Struct Dyn. 2021 Sep;39(15):5756-5767. doi: 10.1080/07391102.2020.1791958. Epub 2020 Jul 20.
10
Natural-like products as potential SARS-CoV-2 M inhibitors: drug discovery.天然产物作为潜在的 SARS-CoV-2 M 抑制剂:药物发现。
J Biomol Struct Dyn. 2021 Sep;39(15):5722-5734. doi: 10.1080/07391102.2020.1790037. Epub 2020 Jul 8.